Free Communication Clinical Orals #4:Type 2 Diabetes & Complications
Tracks
Breakout 4: Room 5
| Wednesday, August 20, 2025 |
| 4:00 PM - 6:00 PM |
| Room 5 |
Speaker
Emma Hamilton
Incident sepsis in people with or without type 2 diabetes: The Fremantle diabetes study phase II
4:00 PM - 4:15 PMBiography
Dr Emma Hamilton is an Endocrinologist at Fiona Stanley and Fremantle Hospitals, Clinical Senior Lecturer at UWA and Endocrinology Lead of the Multidisciplinary Diabetes Foot Unit at Fiona Stanley Hospital, an NADC accredited Centre of Excellence High Risk Foot Service. Emma’s research interests include diabetes, osteoporosis and diabetes-related foot complications.
Dr Yingting Tina Cao
Lecturer
La Trobe University
Lipidome-predicted dietary pattern scores and their associations with cardiometabolic risk factors in Australian adults
4:15 PM - 4:30 PMBiography
Dr Tina Cao is a lecturer and public health nutrition researcher at La Trobe University. Her research focuses on dietary patterns, cardiometabolic health, and health equity in culturally diverse populations. She also collaborates on lipidomics projects to advance biomarker-informed nutrition research and precision dietary assessment.
Dr Julian Sacre
Postdoctoral Research Fellow
Baker Heart and Diabetes Institute
Differentiation between atherosclerotic cardiovascular disease and heart failure risk in type 2 diabetes: a new multi-outcome risk score
4:30 PM - 4:45 PMBiography
Dr Julian Sacre is a mid-career researcher who has worked at the Baker Heart and Diabetes Institute since 2012. He is with the Clinical Diabetes and Epidemiology team, and the focus of his research is on cardiorenal complications.
Dr Callum Baker
Postdoctoral Fellow
University Of Sydney
Addressing physical inactivity in diabetes-related foot ulcers: a pilot RCT of bespoke aerobic and resistance training for people with diabetes and an active foot ulcer
4:45 PM - 5:00 PMBiography
Callum Baker is an exercise physiologist and physical activity research at the University of Sydney.
Dr Julian Sacre
Postdoctoral Research Fellow
Baker Heart and Diabetes Institute
Predicting when heart failure precedes atherosclerotic disease as the first major cardiovascular event in type 2 diabetes: Findings from the REWIND and ORIGIN trials
5:00 PM - 5:15 PMBiography
Dr Julian Sacre is a mid-career researcher who has worked at the Baker Heart and Diabetes Institute since 2012. He is with the Clinical Diabetes and Epidemiology team, and the focus of his research is on cardiorenal complications.
Dr Emma Hartley
Advanced Trainee
Camden Hospital / South Western Sydney Local Health District
Prof Elif Ekinci
Head Of Department, Medicine Melbourne Medical School
University of Melbourne
Dynamic contrast enhanced MRI to assess add-on Empagliflozin effect on kidney function in people with Type 2 diabetes
5:30 PM - 5:45 PMBiography
Professor Elif Ekinci is Head of the Department of Medicine at the University of Melbourne and Director of ACADI. A clinician-researcher in diabetes, she has shaped national guidelines and led transformative initiatives to improve diabetes care, research equity, and outcomes across Australia.
Dr Jedidiah Morton
Research Fellow
Monash University
Quantifying the impact of inequality on traditional and emerging diabetes complications: A registry study of cause-specific admissions in Australia
5:45 PM - 6:00 PMBiography
Jed's research interests include epidemiology, epidemiological modelling, and health economic analysis of diabetes, cardiovascular disease, and kidney disease.
Dr Anna Galligan
Endocrinologist
St Vincent's Hospital Melbourne
Chairperson
Biography
Prof Stephen Twigg
Kellion Prof of Endocrinology and Stan Clark Chair In Diabetes; HOD RPAH Endocrinology
University of Sydney / Royal Prince Alfred Hospital
Chairperson
Biography
Prof. Stephen Twigg is Kellion Professor of Endocrinology and Stan Clark Chair in Diabetes at the University of Sydney, and Head of RPAH Endocrinology Department, Sydney. As a past- President of the ADS, current Diabetes Feet Australia Strategic planning committee member and past ADS Kellion Awardee, he is well recognised for his academic and clinical leadership in diabetes and its complications. He has published more than 250 scientific articles, with 15,000+ citations, and been primary supervisor of 18 PhD students. His presentation will focus on the challenging topic of painful neuropathy in diabetes, including its identification and progress in management
